Loading
RIMA·Psychiatry - Antidepressants
Major Depressive Disorder, Social Phobia
Max Dose
600 mg/day
Half-life
1-2 h
Diet Restrictions
MINIMAL
Interactions
HIGH
Overview
Reversible Inhibitor of Monoamine Oxidase A (RIMA). Provides the unique efficacy of an MAOI without the terrifying, strict dietary restrictions (cheese effect).
Maximum Dose
Max 600 mg/day (e.g., 300 mg BD).
Clinical Focus
While food interactions are rare, the drug interactions are STILL FATAL. Mixing Moclobemide with an SSRI will cause fatal Serotonin Syndrome.
Bottom Line
Moclobemide is a reversible MAOI (RIMA) for depression with fewer dietary restrictions than irreversible MAOIs, but still carries serotonin syndrome risk and requires a washout period from other antidepressants.
Brand Names
Aurorix, Amira
Oral Routes
Tablets (150 mg, 300 mg).
Prescribing & PBS
Unrestricted General Benefit (S4).
Primary
Major Depressive Disorder, Social Phobia.
Clinical Place
A highly underutilized, excellent drug for social anxiety and atypical depression. Safer than irreversible MAOIs (Phenelzine).